Cargando…

Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection

To prevent autoimmunity, thymocytes expressing self-reactive T cell receptors (TCRs) are negatively selected, however, divergence into tolerogenic, agonist selected lineages represent an alternative fate. As thymocyte development, selection, and lineage choices are dependent on spatial context and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Heimli, Marte, Flåm, Siri Tennebø, Hjorthaug, Hanne Sagsveen, Trinh, Don, Frisk, Michael, Dumont, Karl-Andreas, Ribarska, Teodora, Tekpli, Xavier, Saare, Mario, Lie, Benedicte Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895842/
https://www.ncbi.nlm.nih.gov/pubmed/36741401
http://dx.doi.org/10.3389/fimmu.2022.1092028
_version_ 1784881932399542272
author Heimli, Marte
Flåm, Siri Tennebø
Hjorthaug, Hanne Sagsveen
Trinh, Don
Frisk, Michael
Dumont, Karl-Andreas
Ribarska, Teodora
Tekpli, Xavier
Saare, Mario
Lie, Benedicte Alexandra
author_facet Heimli, Marte
Flåm, Siri Tennebø
Hjorthaug, Hanne Sagsveen
Trinh, Don
Frisk, Michael
Dumont, Karl-Andreas
Ribarska, Teodora
Tekpli, Xavier
Saare, Mario
Lie, Benedicte Alexandra
author_sort Heimli, Marte
collection PubMed
description To prevent autoimmunity, thymocytes expressing self-reactive T cell receptors (TCRs) are negatively selected, however, divergence into tolerogenic, agonist selected lineages represent an alternative fate. As thymocyte development, selection, and lineage choices are dependent on spatial context and cell-to-cell interactions, we have performed Cellular Indexing of Transcriptomes and Epitopes by sequencing (CITE-seq) and spatial transcriptomics on paediatric human thymu​​s. Thymocytes expressing markers of strong TCR signalling diverged from the conventional developmental trajectory prior to CD4(+) or CD8(+) lineage commitment, while markers of different agonist selected T cell populations (CD8αα(I), CD8αα(II), T((agonist)), T(reg)(diff), and T(reg)) exhibited variable timing of induction. Expression profiles of chemokines and co-stimulatory molecules, together with spatial localisation, supported that dendritic cells, B cells, and stromal cells contribute to agonist selection, with different subsets influencing thymocytes at specific developmental stages within distinct spatial niches. Understanding factors influencing agonist T cells is needed to benefit from their immunoregulatory effects in clinical use.
format Online
Article
Text
id pubmed-9895842
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98958422023-02-04 Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection Heimli, Marte Flåm, Siri Tennebø Hjorthaug, Hanne Sagsveen Trinh, Don Frisk, Michael Dumont, Karl-Andreas Ribarska, Teodora Tekpli, Xavier Saare, Mario Lie, Benedicte Alexandra Front Immunol Immunology To prevent autoimmunity, thymocytes expressing self-reactive T cell receptors (TCRs) are negatively selected, however, divergence into tolerogenic, agonist selected lineages represent an alternative fate. As thymocyte development, selection, and lineage choices are dependent on spatial context and cell-to-cell interactions, we have performed Cellular Indexing of Transcriptomes and Epitopes by sequencing (CITE-seq) and spatial transcriptomics on paediatric human thymu​​s. Thymocytes expressing markers of strong TCR signalling diverged from the conventional developmental trajectory prior to CD4(+) or CD8(+) lineage commitment, while markers of different agonist selected T cell populations (CD8αα(I), CD8αα(II), T((agonist)), T(reg)(diff), and T(reg)) exhibited variable timing of induction. Expression profiles of chemokines and co-stimulatory molecules, together with spatial localisation, supported that dendritic cells, B cells, and stromal cells contribute to agonist selection, with different subsets influencing thymocytes at specific developmental stages within distinct spatial niches. Understanding factors influencing agonist T cells is needed to benefit from their immunoregulatory effects in clinical use. Frontiers Media S.A. 2023-01-20 /pmc/articles/PMC9895842/ /pubmed/36741401 http://dx.doi.org/10.3389/fimmu.2022.1092028 Text en Copyright © 2023 Heimli, Flåm, Hjorthaug, Trinh, Frisk, Dumont, Ribarska, Tekpli, Saare and Lie https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Heimli, Marte
Flåm, Siri Tennebø
Hjorthaug, Hanne Sagsveen
Trinh, Don
Frisk, Michael
Dumont, Karl-Andreas
Ribarska, Teodora
Tekpli, Xavier
Saare, Mario
Lie, Benedicte Alexandra
Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection
title Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection
title_full Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection
title_fullStr Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection
title_full_unstemmed Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection
title_short Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection
title_sort multimodal human thymic profiling reveals trajectories and cellular milieu for t agonist selection
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895842/
https://www.ncbi.nlm.nih.gov/pubmed/36741401
http://dx.doi.org/10.3389/fimmu.2022.1092028
work_keys_str_mv AT heimlimarte multimodalhumanthymicprofilingrevealstrajectoriesandcellularmilieufortagonistselection
AT flamsiritennebø multimodalhumanthymicprofilingrevealstrajectoriesandcellularmilieufortagonistselection
AT hjorthaughannesagsveen multimodalhumanthymicprofilingrevealstrajectoriesandcellularmilieufortagonistselection
AT trinhdon multimodalhumanthymicprofilingrevealstrajectoriesandcellularmilieufortagonistselection
AT friskmichael multimodalhumanthymicprofilingrevealstrajectoriesandcellularmilieufortagonistselection
AT dumontkarlandreas multimodalhumanthymicprofilingrevealstrajectoriesandcellularmilieufortagonistselection
AT ribarskateodora multimodalhumanthymicprofilingrevealstrajectoriesandcellularmilieufortagonistselection
AT tekplixavier multimodalhumanthymicprofilingrevealstrajectoriesandcellularmilieufortagonistselection
AT saaremario multimodalhumanthymicprofilingrevealstrajectoriesandcellularmilieufortagonistselection
AT liebenedictealexandra multimodalhumanthymicprofilingrevealstrajectoriesandcellularmilieufortagonistselection